申请人:Mitsubishi Kasei Corporation
公开号:US05116858A1
公开(公告)日:1992-05-26
4-Imidazoline derivatives represented by the formula (I) and/or formula (II): ##STR1## wherein R.sup.1 represents C.sub.1 -C.sub.8 alkyl, C.sub.3 -C.sub.8 alkenyl, C.sub.3 -C.sub.8 alkynyl, C.sub.3 -C.sub.8 cycloalkyl, or optionally substituted aralkyl; R.sup.2 and R.sup.3 independently represent hydrogen, C.sub.3 -C.sub.20 alkyl, C.sub.3 -C.sub.20 alkenyl, C.sub.3 -C.sub.20 alkynyl, C.sub.3 -C.sub.20 alkoxy, C.sub.3 -C.sub.20 alkenyloxy, C.sub.3 -C.sub.20 alkynyloxy, C.sub.3 -C.sub.8 cyloalkyl, C.sub.1 -C.sub.10 alkylthio, or optionally substituted aralkyl or aralkyloxy; R.sup.4 represents C.sub.1 -C.sub.6 alkyl, C.sub.3 -C.sub.8 cycloalkyl, or optionally substituted aralkyl; provided that R.sup.2 and R.sup.3 cannot be hydrogen at the same time, and pharmaceutically acceptable salts thereof. A pharmaceutical formulation containing the compound is also provided.
式(I)和/或式(II)所表示的4-咪唑啉衍生物:##STR1## 其中,R.sup.1代表C.sub.1-C.sub.8烷基,C.sub.3-C.sub.8烯基,C.sub.3-C.sub.8炔基,C.sub.3-C.sub.8环烷基,或可选的取代芳基烷基;R.sup.2和R.sup.3独立地代表氢,C.sub.3-C.sub.20烷基,C.sub.3-C.sub.20烯基,C.sub.3-C.sub.20炔基,C.sub.3-C.sub.20烷氧基,C.sub.3-C.sub.20烯氧基,C.sub.3-C.sub.20炔氧基,C.sub.3-C.sub.8环烷基,C.sub.1-C.sub.10烷基硫醚,或可选的取代芳基烷基或芳基烷氧基;R.sup.4代表C.sub.1-C.sub.6烷基,C.sub.3-C.sub.8环烷基,或可选的取代芳基烷基;前提是R.sup.2和R.sup.3不能同时为氢,以及其药学上可接受的盐。还提供了含有该化合物的制药配方。